CIN 2/3

Clinical trials for CIN 2/3 explained in plain language.

Never miss a new study

Get alerted when new CIN 2/3 trials appear

Sign up with your email to follow new studies for CIN 2/3, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New vaginal treatment tested to reverse cervical Pre-Cancer

Disease control Recruiting now

This study is testing whether artesunate vaginal inserts can help treat cervical pre-cancer (CIN2/3) and clear the HPV infection that causes it. About 78 women will use either the active inserts or a placebo for three 5-day cycles. The main goal is to see if the treatment causes …

Matched conditions: CIN 2/3

Phase: PHASE2 • Sponsor: Frantz Viral Therapeutics, LLC • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

CIN 2/3

Get alerted when new CIN 2/3 trials appear

New vaginal treatment tested to reverse cervical Pre-Cancer